SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-051879
Filing Date
2014-08-12
Accepted
2014-08-12 16:40:24
Documents
1
Period of Report
2014-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6561
  Complete submission text file 0001209191-14-051879.txt   7992
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2401 FOURTH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Bencich John (Reporting) CIK: 0001477056 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 141034453